Complement activation in children with Streptococcus pneumoniae associated hemolytic uremic syndrome

Area of Science:

• Pediatric Nephrology
• Infectious Diseases
• Complement System Immunology

Background:

• Hemolytic uremic syndrome (HUS) caused by invasive pneumococcal disease (P-HUS) is rare in children.
• P-HUS presents high acute mortality and long-term renal sequelae.
• Alternative complement pathway abnormalities may influence P-HUS pathogenesis and treatment.

Purpose of the Study:

• To assess the clinical course and laboratory data of the acute phase of P-HUS in children.
• To evaluate the outcomes and long-term renal sequelae in pediatric P-HUS patients.

Main Methods:

• Retrospective study of seven children diagnosed with P-HUS.
• Analysis of clinical course, laboratory data, and complement pathway function.
• Genetic analysis for complement risk haplotypes in affected children.

Main Results:

• Seven children (median age 12 months) with P-HUS were studied; meningitis or pneumonia were primary manifestations.
• All patients required dialysis; five recovered renal function after a median of 25 days.
• Complement analysis revealed alternative pathway activation; three patients received eculizumab with one death post-transplant.

Conclusions:

• Disordered complement regulation is implicated in P-HUS pathophysiology.
• Understanding complement pathways may improve diagnosis and targeted P-HUS treatments.
• Further research into complement inhibition could offer new therapeutic strategies.